SM

Shyam Mohan Shukla

Active Director Designated Partner DIN 09402634
DIN 09402634 First appointment Nov 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Shyam Mohan Shukla

Data last updated:

Shyam Mohan Shukla is a Designated Partner at Taiyo Pharmaceutical Llp (since 2021). The company operates in Pharma.

DIN 09402634
Primary Designation Designated Partner
Industry Pharma
First Appointment 17 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner17 Nov 20212021Active

Board colleagues of Shyam Mohan Shukla

NameDINCompanyDesignation
Arvind Shyamnarayan Singh10659436Taiyo Pharmaceutical LlpDesignated Partner
Vijay Pratap Singh09804855Taiyo Pharmaceutical LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Taiyo Pharmaceutical Llp
Premium access

Shareholding and investment profile for Shyam Mohan Shukla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shyam Mohan Shukla

Shyam Mohan Shukla currently holds 1 directorship: Taiyo Pharmaceutical Llp (Designated Partner, since 17 Nov 2021).

Shyam Mohan Shukla was first appointed on 17 Nov 2021 as Designated Partner at Taiyo Pharmaceutical Llp.

The current boards of Shyam Mohan Shukla's companies include Arvind Shyamnarayan Singh (Taiyo Pharmaceutical Llp), Vijay Pratap Singh (Taiyo Pharmaceutical Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available